Bernhard Günther Dipl.-Ing. (FH)
Managing Director/Chief Executive Officer
Bernhard Günther joined Novaliq as Chief Executive Officer in January 2007. He has more than 20 years of experience in the field of biopharmaceutics and medical devices. Prior to Novaliq, Mr. Günther served as Chief Executive Officer of Fluoron GmbH, a German medical device company, which pioneered the development of ophthalmic implants based on semifluorinated alkanes for the treatment of serious retinal diseases.
During his tenure at Fluoron, Mr. Günther was also responsible for the successful development and launch of the long-term endotamponade Densiron® 68 and the intraocular staining solution Brilliant Peel® as well. Mr. Günther was for 10 years the Head of Regulatory Affairs and Managing Director for Marketing and Sales at Geuder AG, a leading ophthalmosurgical company in Germany. He also served as a member on the Board of Fluoron GmbH. Mr. Günther holds a Diploma in Polymer Engineering from the University of Applied Sciences in Darmstadt, Germany.